LIPIDS: 60 Second Insights

Published: 10 August 2018

  • Views:

    Views Icon 975
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 5 | Session 2 of 2
    Wolfgang Koenig
    Wolfgang Koenig
    Up Next
Average (ratings)
No ratings
Your rating

Overview

A short series of 60-second insight videos on the LIPIDS trial.

More from this programme

Part 1

Which emerging compounds show the most promise in reducing LDL?

Part 2

What is required for PCSK9s to get wider spread adoption?

Part 3

How important is inflammation in atherosclerosis?

Part 4

Are statins over (or under) prescribed?

Part 5

Is cholesterol being managed sub- optimally? If so, what needs to improve?

Part 6

How low should LDL go?

Part 7

Is HDL good cholesterol?

Part 8

What is the greatest unmet need in lipid management?

Faculty Biographies

Wolfgang Koenig

Wolfgang Koenig

Professor of Medicine/Cardiology

Wolfgang Koenig is a Professor of Medicine/Cardiology. He is a board-certified internist and interventional cardiologist specialized in intensive care medicine and has extensive experience in the molecular epidemiology of cardiovascular diseases. A former Director of the WHO-MONICA Augsburg Myocardial Infarction Register, Professor Koenig has held multiple clinical positions at the University of Ulm Medical Center. In April 2015 he joined the Deutsches Herzzentrum München, Technische Universität München and became an established investigator of the Munich Heart Alliance within the German Centre for Cardiovascular Research (DZHK) and is the Head of the Cardiometabolic Unit.

Professor Koenig serves on the steering committee of multiple large, international randomised clinical trials testing innovative targets in cardiovascular medicine. His research investigates the molecular basis of atherothrombogenesis including the interrelationship between hemostasis, inflammation, and…

View full profile